Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-18-000004
Filing Date
2018-01-08
Accepted
2018-01-08 17:02:09
Documents
1
Period of Report
2018-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 39720
  Complete submission text file 0001325812-18-000004.txt   41094
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 3RD STREET CAMBRIDGE MA 02142
Business Address
Mason Michael (Reporting) CIK: 0001514291 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 18517046